메뉴 건너뛰기
Anesthesia and Analgesia
Volumn 111, Issue 6, 2010, Pages 1347-1352
Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban
Author keywords

[No Author keywords available]
Indexed keywords

ARGATROBAN; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 2; COAGULATING AGENT; HEPARIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;
EID: 78650304606     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181fbc120     Document Type: Article
Times cited : (6)
References (10)
  • 1
    • 70349113093 scopus 로고    scopus 로고
    • Argatroban: A review of its use in the management of heparin-induced thrombocytopenia
    • Dhillon S. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia. Am J Cardiovasc Drugs 2009;9:261-82
    • (2009) Am J Cardiovasc Drugs , vol.9 , pp. 261-82
    • Dhillon, S.1
  • 2
    • 68149089854 scopus 로고    scopus 로고
    • Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma
    • Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma. Blood Coagul Fibrinolysis 2009;20:377-80
    • (2009) Blood Coagul Fibrinolysis , vol.20 , pp. 377-80
    • Nielsen, V.G.1    Kirklin, J.K.2    George, J.F.3
  • 3
    • 69549108991 scopus 로고    scopus 로고
    • Carbon monoxide releasing molecule-2 decreases fibrinolysis in human plasma
    • Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 decreases fibrinolysis in human plasma. Blood Coagul Fibrinolysis 2009;20:448-55
    • (2009) Blood Coagul Fibrinolysis , vol.20 , pp. 448-55
    • Nielsen, V.G.1    Kirklin, J.K.2    George, J.F.3
  • 4
    • 75649137350 scopus 로고    scopus 로고
    • Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII deficient plasmas
    • Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and factor VII deficient plasmas. Blood Coagul Fibrinolysis 2010;21:41-5
    • (2010) Blood Coagul Fibrinolysis , vol.21 , pp. 41-5
    • Nielsen, V.G.1    Kirklin, J.K.2    George, J.F.3
  • 5
    • 27744492554 scopus 로고    scopus 로고
    • Therapeutic applications of carbon monoxide-releasing molecules
    • Motterlini R, Mann BE, Foresti, R. Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 2005;14:1305-18
    • (2005) Expert Opin Investig Drugs , vol.14 , pp. 1305-18
    • Motterlini, R.1    Mann, B.E.2    Foresti, R.3
  • 6
    • 75649133252 scopus 로고    scopus 로고
    • Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and factor XIII deficient plasma
    • Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and factor XIII deficient plasma. Blood Coagul Fibri-nolysis 2010;21:101-5
    • (2010) Blood Coagul Fibri-nolysis , vol.21 , pp. 101-5
    • Nielsen, V.G.1    Kirklin, J.K.2    George, J.F.3
  • 7
    • 77951902971 scopus 로고    scopus 로고
    • Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance pro-thrombin activity
    • Nielsen VG, Malayaman SN, Khan ES, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance pro-thrombin activity. Blood Coagul Fibrinolysis 2010;21:349-53
    • (2010) Blood Coagul Fibrinolysis , vol.21 , pp. 349-53
    • Nielsen, V.G.1    Malayaman, S.N.2    Khan, E.S.3    Kirklin, J.K.4    George, J.F.5
  • 8
    • 14644440824 scopus 로고    scopus 로고
    • Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: Critical roles of fibrinogen and factors II, VII, X and XII
    • Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 2005;49:222-31
    • (2005) Acta Anaesthesiol Scand , vol.49 , pp. 222-31
    • Nielsen, V.G.1    Cohen, B.M.2    Cohen, E.3
  • 9
    • 57149108951 scopus 로고    scopus 로고
    • Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII
    • Nielsen VG, Kirklin JK. Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII. Blood Coagul Fibrinolysis 2008;19:793-800
    • (2008) Blood Coagul Fibrinolysis , vol.19 , pp. 793-800
    • Nielsen, V.G.1    Kirklin, J.K.2
  • 10
    • 77950275124 scopus 로고    scopus 로고
    • Carbon monoxide releasing molecule-2 enhances coagulation in rat and rabbit plasma
    • Nielsen VG, Khan ES, Huneke RB. Carbon monoxide releasing molecule-2 enhances coagulation in rat and rabbit plasma. Blood Coagul Fibrinolysis 2010;21:298-9
    • (2010) Blood Coagul Fibrinolysis , vol.21 , pp. 298-9
    • Nielsen, V.G.1    Khan, E.S.2    Huneke, R.B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.